Back to VRTX Stock Lookup

Vertex Pharma (VRTX) – Company Press Releases

Feb 11, 2015 04:05 PM Vertex to Present at Upcoming Investor Conferences
Jan 28, 2015 04:01 PM Vertex Reports Full-Year and Fourth Quarter 2014 Financial Results and Provides Guidance for 2015
Jan 11, 2015 08:49 PM Vertex Outlines 2015 Business Priorities to Support the Development, Approval and Launch of New Medicines for the Treatment of People with Cystic Fibrosis
Jan 6, 2015 04:01 PM Vertex Announces Upcoming Presentation at the J.P. Morgan Healthcare Conference and Date of Fourth Quarter and Full Year 2014 Financial Results
Dec 29, 2014 03:11 PM U.S. Food and Drug Administration Approves KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation
Dec 15, 2014 09:00 AM David Altshuler, M.D., Ph.D., Joins Vertex as Executive Vice President of Global Research and Chief Scientific Officer

Back to VRTX Stock Lookup